Back to results
US 6,855,713 B2Granted
Benzimidazole derivatives, a process for their manufacture and use as a medicine
AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG
InventorsPascale Pouzet, Christoph Hoenke, Claudia Heine, Ralf Anderskewitz, Horst Dollinger, Herbert Nar, Hans Michael Jennewein, Bernd Disse
Life of this patent
Estimating the term…
Abstract
The invention concerns benzimidazole derivatives of the general formula (I) in which the radicals R1, R2, R3, X1 and A can have the meanings assigned to them in the specification, their prodrugs, processes for their production as well as the use of the benzimidazole derivatives as medicines, especially as medicines that have trypsin-inhibiting action.
Claims14
A compound of the formula (I):
- wherein:
- R1 represents C1-C10-alkyl or C3-C6-cycloalkyl, each optionally substituted once, twice or three times by any one or more of the following groups:
- C1-C4-alkoxy, phenoxy, hydroxyphenoxy, C1-C4-alkoxy-phenoxy, C3-C6-cycloalkyl, —NH2, —NH(C1-C4-alkyl), —N(C1-C4-alkyl)2, —NH—CO—(C1-C4-alkyl), —CO—NH2, —CO—NH—(C1-C4-alkyl) or —NH—CO-benzyl, or
- represents phenyl-C1-C4-alkyl, in which the phenyl ring may be optionally substituted once, twice or three times by any one or more of the following radicals:
- C1-C4-alkyl, CF3, fluorine, chlorine, bromine, COOH or COO—C1-C4-alkyl,
- R2 is —C(═NH)NH2 or —CH2-NH2;
- X1 is —CO—;
- A together with the adjacent nitrogen forms a piperidine or piperazine ring;
- R3 represents a radical selected from the groups (a), (b) and (c):
- (a) is —NR4R5;
- ·in which
- R4 is hydrogen or a radical of the formula:
- B-(CH2)r—X2—
- wherein:
- B represents a C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkinyl, C1-C6-alkoxy-C1-C6-alkyl, C3-C8-cycloalkyl, phenyl, naphthyl, in which the phenyl, naphthyl group can be substituted by any one or more groups selected from halogen, nitro, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkyl-SO2—, C1-C4-alkyl-PO2—O—, C1-C5-alkanoyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkyl, C1-C4-haloalkoxy, C1-C4-haloalkylthio, C1-C4-cyanoalkyl, C1-C4-hydroxyalkyl, C1-C4-alkoxy-C1-C4-alkyl, carboxy, amino, C1-C4-alkylamino, di-(C1-C4-alkyl)-amino, aminosulfonyl, phenyl and hydroxy, or
- B represents a phenyl group in which two adjacent carbon atoms are jointly substituted by a C1-C4-alkylenedioxy;
- X2 represents CO, NH—CO, SO2, NH—SO2, or a single bond, and
- r is 0 or a whole number from 1 to 4,
- R5 represents hydrogen or a radical of the formula
- D—(CH2)t—,
- in which
- D represents C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy-C1-C6-alkyl, C3-C8-cycloalkyl, phenyl, naphthyl, in which each phenyl, naphthyl group can be substituted by any one or more of the groups selected from:
- halogen, nitro, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkyl-SO2—, C1-C4-alkyl-PO2—O—, C1-C5-alkanoyl, C1-C4-alkoxycarbonyl, C1-C4-haloalkyl, C1-C4-haloalkoxy, C1-C4-haloalkylthio, C1-C4-cyanoalkyl, C1-C4-hydroxyalkyl, C1-C4-alkoxy-C1-C4-alkyl, carboxy, amino, C1-C4-alkylamino, di-(C1-C4-alkyl)-amino, aminosulphonyl, phenyl and hydroxy, or
- D represents a phenyl group, in which two adjacent carbon atoms are jointly substituted by C1-C4-alkylenedioxy;
- and
- t is 0 or a whole number from 1 to 4;
- (b) is —E-phenyl,
- in which
- E stands for —CH2CH2— or —CH═CH—;
- (c) is phenyl, which is substituted by any one or more substituents selected from halogen, trifluoromethyl and nitro;
- or a tautomer, racemate, enantiomer, diastereoisomer or mixture thereof,
- or a pharmacologically unobjectionable acid-addition salt thereof.
29 more elements
Dependencies are inferred from the claim text.